Navigation Links
Bayer Wins Positive Response For Marketing Its Cancer Drug

European officials have given the green signal for Bayer AG and its partner Onyx Pharmaceuticals Inc., for marketing their new drug to treat kidney cancer//.

The opinion of the European Committee for Medicinal Products for Human Use (CHMP) of the drug Nexavar would now be passed onto the European Commission.

A positive ruling by the commission could pave the way for a marketing authorisation for all EU nations in the second half of this year.

The announcement coincided with Bayer's annual general meeting in Cologne, where the group's chief Werner Wenning sought to secure shareholders' support for the planned 16.5 billion euros ($21 billion) takeover of rival pharmaceuticals firm Schering AG.

Describing the proposed acquisition as a milestone in the company's history, Wenning said that this move was the "right step" for the group.

The takeover, Wenning said, would propel Bayer into "the top league of pharmaceutical makers around the world".

Wenning went on to tell the company's shareholders that the acquisition would result in the health services section emerging as the key engine for growth.

Bayer's 86-euro a share offer for Berlin based Schering runs until the end of May with the takeover representing the biggest acquisition in Bayer's corporate history.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
2. Genomatix Licensed By Bayer Healthcare
3. Bayer to Market Biocon Insulin in China
4. Test for Esophageal Reflux Licensed to Bayer by University
5. The Positive Effects Of A Healthy Lifestyle
6. The Positive Effects Of A Healthy Lifestyle
7. Positive Thinking
8. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. HIV Positive People Touching 60,000 In UK
11. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes

Post Your Comments:
(Date:12/3/2009)...than 1,500 Jobs Listed through APHA,s Public Healt...ire-USNewswire/ -- Today,s White House jobs summit... many professions, including public health. One pu...onnect job seekers to more than 1,500 jobs in the ...ttp://www.apha.org/about/careers/ is a full onlin...
(Date:12/3/2009)...stics play a major role in determining who succeed...lished in the November issue of the Journal of Ap...rsity of Minnesota psychology professor Deniz Ones...rough their seven-year medical school career, inve...e to learning and performance in general. , Duri...
(Date:12/3/2009)... 450 Deaths a day is still too many - stalled mom... Atlanta, GA, Geneva, New York,... The Measles Initiative announced today that measl...008, from an estimated 733 000 in 2000 to 164 000 ... of a resurgence in measles deaths if vaccination ...
(Date:12/3/2009)... Henninger,s creative staff caps off successful 2... work and 5 awards for post production services. ... -- The 13th Annual TIVA Peer Awards were presente...onal Press Club in Washington, D.C. last week. He...apped off a successful year for its creative team,...
(Date:12/3/2009)...tes: A Deeper Look Educates Americans About Thi... All Ages ,, DETROIT, Dec. 3 /PRNewswire-USNe...osed with diabetes every 21 seconds. On December 5...newest exhibit, Diabetes: A Deeper Look, to help... diabetes, diabetes treatment and the role insulin...
Breaking Medicine News(10 mins):Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2Health News:Personality predicts success in medical school, says new study by U of Minnesota professor 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Henninger Media Services Wins 9 TIVA Peer Awards 2Health News:Henninger Media Services Wins 9 TIVA Peer Awards 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 2Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 4
... MinuteClinic, the pioneer and largest provider o...ed that it has become a participating provider in ... of South Carolina. , , BlueCross, Preferred Blue...ss BlueShield of South Carolina is an independent ...
...Feb. 5 Palomar Medical Technologies, Inc. (Nasdaq...light-based systems for cosmetic treatments, today...r and year ended December 31, 2008. Revenues for ... were funded development revenues, and $1.25 milli...
...ISCO, Calif., Feb. 5 Rigel,Pharmaceuticals, Inc. ...wer, the,company,s chairman and chief executive of...at the 11th Annual BIO CEO & Investor Conferen...http://www.rigel.com . Please connect to Rigel,s w...
...b. 5 ATS Medical, Inc.,(Nasdaq: ATSI ), manufac...gery,products and services, announced today that t...A) has granted approval for commercialization of t..., (Logo: http://www.newscom.com/cgi-bin/prnh...
... Validation Study Affirms Highly Automated Ca...g Development , Rochester...chnologies, Inc., a leading innovator in advanced ... companies. The study validated the use of its Hig...
...rs from Boston Medical Center (BMC) and Boston Uni...process to minimize discharge failures. The Re-Eng...tilization within 30 days of discharge by over 30 ...ve hospitalizations is complicated by a post-disch...
Other Medicine News:Health News:MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10Health News:ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis 2Health News:ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis 3Health News:iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies 2Health News:iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies 3Health News:Researchers design re-engineered hospital discharge program to reduce rehospitalization 2
(Date:12/3/2009)...FORT WORTH, Texas, Dec. 3 /PRNewswire-FirstCall/...letin Board: WNDM), a rapidly growing provider of ...eement with the Health Industry Representative Ass...ndent sales and marketing representative to market...thin the U.S. ,, HIRA will market and sell Wou...
(Date:12/3/2009)...IEGO, Dec. 3 Cardium The...its wholly-owned subsidiary, Tissue Repair Company... with the U.S. Food and Drug Administration (FDA) ... product candidate based on positive data from th...nical study. Today,s submission with the FDA cove...
(Date:12/3/2009)...YORK, Dec. 3 Alzheimer,s disease (...erson can receive. This irreversible, progressive ...skills and eventually even the ability to carry ou...entia among older people, AD affects as many as 2....he National Institute on Aging. ,, (Logo: ht...
Breaking Medicine Technology:Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3Recovery act funded research projects aid communities across the country 9428 1Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2State Report Ranks LIJ as New Yorks Best for Heart Bypass Surgery North Shore University Hospital Tops for Emergency Angioplasty Survival 53235 1State Report Ranks LIJ as New Yorks Best for Heart Bypass Surgery North Shore University Hospital Tops for Emergency Angioplasty Survival 53235 2
Halogen Lightsources
CMX2-300
NSL-8
NSL-5
Medicine Products: